Editorial
Copyright ©The Author(s) 2015.
World J Gastrointest Oncol. May 15, 2015; 7(5): 30-46
Published online May 15, 2015. doi: 10.4251/wjgo.v7.i5.30
Table 1 Inherited mutations in DNA repair genes that increase the risk of gastrointestinal cancer
DNA repair gene(s)Repair pathway(s) affectedCancers with increased risk
BLMHRR[1]Leukemia, lymphoma, colon, breast, skin, lung, auditory canal, tongue, esophagus, stomach, tonsil, larynx, uterus[2]
WRNHRR, NHEJ, long patch BER[3]Soft tissue sarcoma, colorectal, skin, thyroid, pancreatic[4]
Fanconi's anemia genes FANCA, B, C, D1, D2, E, F, G, I, J, L, M, NHRR and TLS[5]Leukemia, liver tumors, solid tumors in many areas including esophagus, stomach and colon[6]
MSH2, MSH6, MLH1, PMS2MMR[7]Colorectal, endometrial[7]
MUTYHBER of A mispaired with 8-OHdG[8]Colon[8]
P53HRR, BER, NER, NHEJ, MMR[9]Sarcoma, breast, osteo-sarcoma, brain, adreno-cortical carcinomas[10] and colon and pancreas[11]
Table 2 Endogenous DNA damages/cell/day for humans
DNA damagesReported rate of occurrence
Oxidative damages10000[24]
Depurinations9000[25]
Depyrimidations696[26]
Single-strand breaks55000[26]
Double-strand breaksApproximately 50/cell cycle[27]
O6-methylguanine3120[26]
Cytosine deamination192[26]
Table 3 Epigenetic deficiency of DNA repair genes in gastrointestinal cancers and field defects
CancerGeneFrequency in cancerFrequency in adjacentfield defect
Colorectal[17]MGMT46%34%
Colorectal[19]MGMT47%11%
Colorectal[60]MGMT with MSI70%60%
Colorectal[19]MSH213%5%
Colorectal[61]MBD4FrequentFrequent
Colorectal[62]ERCC1100%40%
Colorectal[62]PMS288%50%
Colorectal[62]XPF55%40%
Colorectal[63]WRN29%13%
Stomach[64]MGMT88%78%
Stomach[65]MLH173%20%
Esophagus[66]MLH177%-100%23%-79%
Table 4 CpG island hyper- (and hypo-) methylation of DNA repair genes in cancers
CancerGeneFrequency of promoter hyper-(or hypo-) methylation in cancer
ColorectalLIG482%[78]
MGMT40%-90%[17-21]
ERCC138%[79]
WRN29%-38%[63,80]
MLH19%-10%[22,81]
FEN1Frequent (hypo-)[82]
MBD4Frequent (hyper-)[61]
EsophagealMGMT23%-79%[65,83,84]
MLH143%[82], 64%[85]
MSH229%[83], 75%[84]
StomachMGMT88%[60]
MLH173%[64]
WRN24%-25%[80,86]
FEN1Frequent (hypo-)[82]
Gastric lymphomaATM11%[87]
Table 5 Epigenetic ↑ or ↓ miRNAs, altered in cancers, targeting DNA repair genes
Specific miRNADNA repair gene targetsCancers affected (frequency if measured)References indicating epigenetic control of miRNAReferences indicating target gene(s) of miRNAsReferences indicating cancer type(s) affected
miR-103 miR-107RAD51, RAD51DOsteosarcoma, lung, endometrial, stomach[100][101][101]
miR-34cUNGGastric (70%) field defect gastric (27%) colon (98%) field defect colon (60%) chronic lymphocytic leukemia (18%) small-cell lung cancer (67%) NSCLC (26%)[102,104][103][102,105,106]
miR-31PARP1MLH1SMUG1MMS19Esophagus (47%) colon[72][21][71,107,108]
miR-124KU70Colon[109][110][109]
miR-155RAD51MLH1MSH2MSH6Breast Colon[90,111][23,112][23,90]
let-7a repression increases HMGA2; HMGA2 alters chromatin architecture of and represses ERCC1)ERCC1(Colon) Anaplastic astrocytoma[90][92,113][113]
Let-7b repression increases HMGA1; HMGA1 targets P53P53Prostate Colon[90][114,115][114,115]
miR-182BRCA1NBNRAD17Breast Colon[116][117,118][107,117,119]
Table 6 Median mutation frequencies and ranges
Parent/child per generation orcancer typeMutation frequency per million basesMutation frequency per diploid genome
Parent/child per generation0.0000002330-70
Colorectal carcinomaApproximately 5Approximately 30000
MSS colon cancer2.816800
MSI colon cancer (mismatch DNA repair deficient)47282000
Hepatocellular carcinoma4.225200
Esophageal carcinoma (single nucleotide variants)2.816994
Range 0.7-9.3Range 4516-56528
Esophageal carcinoma (small insertions and deletions)994 Range 262-3573